Detalles de la búsqueda
1.
Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapy.
Cancer Immunol Immunother
; 71(11): 2829-2836, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35348812
2.
Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain.
BMC Cancer
; 15: 1011, 2015 Dec 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26704632
3.
Phase I Study: Safety and Efficacy of an Ex Vivo-Expanded Allogeneic Natural Killer Cell (MG4101) with Rituximab for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma.
Transplant Cell Ther
; 29(4): 253.e1-253.e9, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36610490
4.
Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell.
Cell Immunol
; 276(1-2): 122-7, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22613008
5.
Abnormal Development of Neural Stem Cell Niche in the Dentate Gyrus of Menkes Disease.
Int J Stem Cells
; 15(3): 270-282, 2022 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35220279
6.
Therapeutic Effect of IL1ß Priming Tonsil Derived-Mesenchymal Stem Cells in Osteoporosis.
Tissue Eng Regen Med
; 18(5): 851-862, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34115339
7.
Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study.
Ann Hepatobiliary Pancreat Surg
; 25(2): 206-214, 2021 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34053923
8.
Erratum: Oh, E., et al. Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through Efficient Tumor-Homing and Cytolytic Ability (Running Title: Cryopreserved NK Cells Exhibit Antitumor Effect). Cancers 2019, 11, 966.
Cancers (Basel)
; 12(11)2020 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33158309
9.
Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients.
Breast Cancer Res Treat
; 113(1): 83-93, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18228133
10.
Overexpression of X-linked inhibitor of apoptosis protein (XIAP) is an independent unfavorable prognostic factor in childhood de novo acute myeloid leukemia.
J Korean Med Sci
; 24(4): 605-13, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19654940
11.
Antiphotoaging and antioxidative activities of natural killer cell conditioned medium following UVB irradiation of human dermal fibroblasts and a reconstructed skin model.
Int J Mol Med
; 44(5): 1641-1652, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31432192
12.
Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through Efficient Tumor-Homing and Cytolytic Ability (Running Title: Cryopreserved NK Cells Exhibit Antitumor Effect).
Cancers (Basel)
; 11(7)2019 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31324057
13.
Safety and immune cell kinetics after donor natural killer cell infusion following haploidentical stem cell transplantation in children with recurrent neuroblastoma.
PLoS One
; 14(12): e0225998, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31834883
14.
Overexpression of Apollon, an antiapoptotic protein, is associated with poor prognosis in childhood de novo acute myeloid leukemia.
Clin Cancer Res
; 13(17): 5109-14, 2007 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17785565
15.
Optimization of Large-Scale Expansion and Cryopreservation of Human Natural Killer Cells for Anti-Tumor Therapy.
Immune Netw
; 18(4): e31, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30181919
16.
Harnessing novel engineered feeder cells expressing activating molecules for optimal expansion of NK cells with potent antitumor activity.
Cell Mol Immunol
; 19(2): 296-298, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34580436
17.
Aven overexpression: association with poor prognosis in childhood acute lymphoblastic leukemia.
Leuk Res
; 30(8): 1019-25, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16388850
18.
Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors.
Cancer Immunol Res
; 4(3): 215-24, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26787822
19.
CD1d-mediated antigen presentation to natural killer T (NKT) cells.
Crit Rev Immunol
; 23(5-6): 403-19, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-15030309
20.
Present and Future of Allogeneic Natural Killer Cell Therapy.
Front Immunol
; 6: 286, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26089823